metformin and 9,10-dimethyl-1,2-benzanthracene

metformin has been researched along with 9,10-dimethyl-1,2-benzanthracene in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Alhaider, AA; Ansari, MA; Denison, MS; El-Kadi, AO; Ghebeh, H; Korashy, HM; Maayah, ZH; Soshilov, AA1
Kurhaluk, N; Tkachenko, H1
Patel, PJ; Shah, JS1

Other Studies

3 other study(ies) available for metformin and 9,10-dimethyl-1,2-benzanthracene

ArticleYear
Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway.
    Toxicology and applied pharmacology, 2015, Apr-15, Volume: 284, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Breast Neoplasms; Carcinogenesis; Carcinogens; Cell Line, Tumor; Cytochrome P-450 CYP1A1; DNA Adducts; Female; Guanine; Humans; Metformin; Mice; NAD(P)H Dehydrogenase (Quinone); Receptors, Aryl Hydrocarbon; RNA, Messenger; Signal Transduction

2015
Effects of melatonin and metformin in preventing lysosome-induced autophagy and oxidative stress in rat models of carcinogenesis and the impact of high-fat diet.
    Scientific reports, 2022, 03-23, Volume: 12, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Autophagy; Carcinogenesis; Diet, High-Fat; Female; Humans; Lysosomes; Mammary Neoplasms, Experimental; Melatonin; Metformin; Oxidative Stress; Rats; Rats, Sprague-Dawley

2022
Metformin pretreatment potentiates the antiproliferative action of doxorubicin against breast cancer.
    Annales pharmaceutiques francaises, 2023, Volume: 81, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Doxorubicin; Female; Metformin; Neoplasms; Rats; Rats, Wistar

2023